{"name":"Johnson & Johnson Consumer Inc. (J&JCI)","slug":"johnson-johnson-consumer-inc-j-jci","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"cardiovascular","drugs":[{"name":"LISTERINE COOL MINT Antiseptic Mouthwash","genericName":"LISTERINE COOL MINT Antiseptic Mouthwash","slug":"listerine-cool-mint-antiseptic-mouthwash","indication":"Reduction of plaque and gingivitis","status":"marketed"},{"name":"Listerine Clinical Solutions Teeth Strength","genericName":"Listerine Clinical Solutions Teeth Strength","slug":"listerine-clinical-solutions-teeth-strength","indication":"Enamel strengthening and tooth sensitivity reduction","status":"marketed"},{"name":"Listerine Experimental Mouthwash","genericName":"Listerine Experimental Mouthwash","slug":"listerine-experimental-mouthwash","indication":"Reduction of plaque and gingivitis","status":"marketed"},{"name":"Listerine Total Care Zero","genericName":"Listerine Total Care Zero","slug":"listerine-total-care-zero","indication":"Reduction of plaque and gingivitis","status":"marketed"}]},{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"F# 13418-148 Eye Drops","genericName":"F# 13418-148 Eye Drops","slug":"f-13418-148-eye-drops","indication":"Dry eye disease (presumed, based on eye drop formulation)","status":"phase_3"},{"name":"F# PF-004390 Eye Drops","genericName":"F# PF-004390 Eye Drops","slug":"f-pf-004390-eye-drops","indication":"Dry eye disease (ocular surface pain)","status":"phase_3"},{"name":"F#13418-158 Eye Drops","genericName":"F#13418-158 Eye Drops","slug":"f-13418-158-eye-drops","indication":"Dry eye disease (presumed, based on formulation type)","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Antiseptic Wash","genericName":"Antiseptic Wash","slug":"antiseptic-wash","indication":"Skin antisepsis and cleansing","status":"marketed"}]}],"pipeline":[{"name":"F# 13418-148 Eye Drops","genericName":"F# 13418-148 Eye Drops","slug":"f-13418-148-eye-drops","phase":"phase_3","mechanism":"F# 13418-148 is an ophthalmic formulation designed to treat dry eye disease by lubricating and protecting the ocular surface.","indications":["Dry eye disease (presumed, based on eye drop formulation)"],"catalyst":""},{"name":"Antiseptic Wash","genericName":"Antiseptic Wash","slug":"antiseptic-wash","phase":"marketed","mechanism":"Antiseptic wash kills or inhibits microorganisms on skin through chemical antimicrobial agents.","indications":["Skin antisepsis and cleansing","Prevention of minor skin infections","Preoperative skin preparation"],"catalyst":""},{"name":"F# PF-004390 Eye Drops","genericName":"F# PF-004390 Eye Drops","slug":"f-pf-004390-eye-drops","phase":"phase_3","mechanism":"PF-004390 is a selective TRPM8 antagonist that blocks cold-sensing ion channels in the eye to reduce ocular pain and discomfort.","indications":["Dry eye disease (ocular surface pain)"],"catalyst":""},{"name":"F#13418-158 Eye Drops","genericName":"F#13418-158 Eye Drops","slug":"f-13418-158-eye-drops","phase":"phase_3","mechanism":"F#13418-158 is an ophthalmic formulation designed to treat dry eye disease by lubricating and protecting the ocular surface.","indications":["Dry eye disease (presumed, based on formulation type)"],"catalyst":""},{"name":"LISTERINE COOL MINT Antiseptic Mouthwash","genericName":"LISTERINE COOL MINT Antiseptic Mouthwash","slug":"listerine-cool-mint-antiseptic-mouthwash","phase":"marketed","mechanism":"Listerine Cool Mint kills oral bacteria and reduces plaque formation through its essential oil and alcohol active ingredients.","indications":["Reduction of plaque and gingivitis","Bad breath control","General oral antisepsis"],"catalyst":""},{"name":"Listerine Clinical Solutions Teeth Strength","genericName":"Listerine Clinical Solutions Teeth Strength","slug":"listerine-clinical-solutions-teeth-strength","phase":"marketed","mechanism":"Listerine Clinical Solutions Teeth Strength is an oral rinse that strengthens tooth enamel and reduces sensitivity through fluoride and essential oil antimicrobial action.","indications":["Enamel strengthening and tooth sensitivity reduction","Plaque and gingivitis reduction"],"catalyst":""},{"name":"Listerine Experimental Mouthwash","genericName":"Listerine Experimental Mouthwash","slug":"listerine-experimental-mouthwash","phase":"marketed","mechanism":"Listerine Experimental Mouthwash kills oral bacteria and reduces plaque formation through its essential oil and antimicrobial active ingredients.","indications":["Reduction of plaque and gingivitis","Halitosis (bad breath) control","General oral antimicrobial activity"],"catalyst":""},{"name":"Listerine Total Care Zero","genericName":"Listerine Total Care Zero","slug":"listerine-total-care-zero","phase":"marketed","mechanism":"Listerine Total Care Zero is an antimicrobial oral rinse that kills bacteria and reduces plaque and gingivitis without alcohol.","indications":["Reduction of plaque and gingivitis","Antimicrobial oral hygiene maintenance"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":8,"phaseCounts":{"phase_3":3,"marketed":5},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}